Not so fast with tricuspid valve interventions -- Analysis of the TRIC-I-HF Trial
The headline study this week in the NEJM was the highly positive TRIC I HF trial of tricuspid valve interventions. Gosh there was a lot to see under the hood of this trial
The POET II trial of two antibiotic strategies of endocarditis is an example where you have to look beyond the primary endpoint and not rely on the authors’ conclusions
Dedicated, personalized patient care; inquiry aimed at improving medical practice; training the next generation so that medicine will continue to improve.
Revisiting one of cardiology’s most important and most ignored trials
Sometimes it’s worth second and third looks at the biggies. The cash machine known as the industry of “preop” clearance rests on little to no data. The CARP Trial
Sometimes there is a causative link; sometimes the presence of an exposure modifies the effect of a causative exposure; and sometimes a close association is only that, an association, a version of the link between carrying a cigarette lighter and developing lung cancer.
Medicine and Public Health Have an Obsession, and It Is Not Health
On the rise of political advocacy in medicine and public health, where it leads us astray, what it costs the public, and the case for a return to political neutrality.
My Mother Wanted to Die at Home. I Wasn’t Prepared.
In an era when most die protracted deaths from chronic disease, this means recognizing that death is not just about the right place, but also the right support. And it’s not just about the dying, but also the family who survive them.
In the end, STAREE will have little effect on my initiation of statins in older patients. SAGA/SITE will modestly increase my rate of statin deprescribing.
In this age of misinformation, where we seem to have become disdainful of genuine experts, no armor will protect us from folly more effectively than a healthy dose of disbelief.
The Curious Case of Using Beta-Blockers in HFrEF may turn on the Patient's Rhythm
The Study of the Week stays with the theme of applying trial evidence to patients, once again in the heart failure field. Perhaps GDMT might not always apply?
Implantable cardiac defibrillators (ICDs)can save lives if a person goes into a shockable rhythm (VT or VF), which would otherwise progress to impaired perfusion and death (termed sudden cardiac death - SCD), but instead, the ICD shocks them back to sinus rhythm.
Things are pretty quiet in the summer so let's go back to an old-school medical reversal in electrophysiology. One I lived through. If you like trials you will like this story
Friday Reflection 62: The Ethics of Telling Patients We Have Nothing Left to Offer
We no longer conceal bad diagnoses from patients; we consider this unethical. It is time that we consider it unethical to conceal that we have nothing to offer beyond palliation.
No appearances yet. If you've seen Adam Cifu as a guest somewhere, hit + suggest to add it.
